Oneok Inc (OKE) 48.62 $OKE Oneok Set to Possibly

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2016 at 7:03 PM

Oneok Inc (OKE) 48.62 $OKE

Oneok Set to Possibly Pullback After Yesterday's Rally of 2.35%
Comtex SmarTrend(R) - Wed Sep 21, 2:00PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $47.56 to a high of $48.41. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $47.89 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OKE: 48.62 (-1.02)

Oneok Set to Possibly Rebound After Yesterday's Selloff of 1.09%
Comtex SmarTrend(R) - Fri Sep 16, 2:24PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $45.89 to a high of $46.54. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $46.47 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OKE: 48.62 (-1.02)

Oneok Falls 1.09% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Sep 16, 2:22PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $45.89 to a high of $46.54. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $46.47 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OKE: 48.62 (-1.02)

Basic Materials Stocks Under Scanner -- BHP Billiton, Turquoise Hill Resources, BHP Billiton, and ONEOK Partners
PR Newswire - Fri Sep 09, 6:45AM CDT
Companies in the Basic Materials space manufacture chemicals, building materials, and paper products, and are also engaged in commodities exploration and processing. The sector offers dividend yields that are above average compared with the wider market. This morning, Stock-Callers.com redirects investors' attention to the following equities: BHP Billiton Ltd (NYSE: BHP), Turquoise Hill Resources Ltd (NYSE: TRQ), BHP Billiton PLC (NYSE: BBL), and ONEOK Partners L.P. (NYSE: OKS). You can access of our complimentary research reports on these stocks now at:
TRQ: 3.05 (-0.03), BHP: 32.54 (+0.08), OKE: 48.62 (-1.02), OKS: 38.65 (-0.61), BBL: 28.49 (-0.11)

Technical Roundup on Gas Utilities Stocks -- ONEOK, Clean Energy Fuels, Questar, and South Jersey Industries
PR Newswire - Thu Sep 08, 12:00PM CDT
Operators in the Gas Utilities space provide services connected to pipeline transmission, distribution, and delivery of natural gas. The global industry is forecasted to grow at a CAGR of 3.2% by the end of 2020. Stock-Callers reviews these equities today: ONEOK Inc. (NYSE: OKE), Clean Energy Fuels Corp. (NASDAQ: CLNE), Questar Corp. (NYSE: STR), and South Jersey Industries Inc. (NYSE: SJI). Sign up today and download for free the research reports for the stocks covered today at: http://stock-callers.com/registration
STR: 25.06 (unch), OKE: 48.62 (-1.02), SJI: 30.68 (-0.25), CLNE: 4.30 (-0.12)

SmarTrend Watching for Potential Pullback in Shares of Oneok After 2.83% Gain
Comtex SmarTrend(R) - Fri Sep 02, 2:01PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $47.73 to a high of $48.87. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $47.87 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OKE: 48.62 (-1.02)

ONEOK and ONEOK Partners to Present at the Barclays CEO Energy Conference
PR Newswire - Thu Sep 01, 3:15PM CDT
ONEOK, Inc. (NYSE: OKE) and ONEOK Partners, L.P. (NYSE: OKS) will participate at the Barclays CEO Energy Conference Sept. 6-7, 2016, in New York City.
OKE: 48.62 (-1.02), OKS: 38.65 (-0.61)

Look for Shares of Oneok to Potentially Rebound after Yesterday's 1.88% Sell Off
Comtex SmarTrend(R) - Wed Aug 24, 2:25PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $47.28 to a high of $48.01. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $47.91 on volume of 534,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OKE: 48.62 (-1.02)

SmarTrend Watching for Potential Rebound in Shares of Oneok After 1.88% Loss
Comtex SmarTrend(R) - Wed Aug 24, 2:23PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $47.28 to a high of $48.01. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $47.91 on volume of 534,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OKE: 48.62 (-1.02)

ONEOK Partners to Participate in Citi MLP Conference
PR Newswire - Tue Aug 16, 3:15PM CDT
ONEOK Partners, L.P. (NYSE: OKS) will participate in the Citi One-on-One Master Limited Partnership/Midstream Infrastructure Conference on Wednesday and Thursday, Aug. 17-18, 2016, in Las Vegas, Nevada.
OKE: 48.62 (-1.02), OKS: 38.65 (-0.61)

Watch for Oneok to Potentially Pullback After Gaining 2.19% Yesterday
Comtex SmarTrend(R) - Fri Aug 12, 2:07PM CDT
Oneok (NYSE:OKE) traded in a range yesterday that spanned from a low of $46.18 to a high of $47.67. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $46.59 on volume of 959,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OKE: 48.62 (-1.02)

Just Energy (JE) Q2 Loss Narrower than Expected, Sales Lag
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:42AM CDT
Just Energy Group Inc. (JE) reported adjusted loss of 4 cents per share in the first quarter of fiscal 2017, narrower than the Zacks Consensus Estimate of a loss of 5 cents
OKE: 48.62 (-1.02), JE: 5.17 (-0.15), OGS: 64.09 (-0.90), NFG: 56.18 (-1.39)

ONEOK Thriving on Higher Distributions & Growth Projects
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 9:07AM CDT
ONEOK Inc. (OKE) continues to develop new projects, mainly in the Williston Basin, Permian Basin and other mineral-rich areas
NWN: 62.40 (-0.60), OKE: 48.62 (-1.02), OKS: 38.65 (-0.61), JE: 5.17 (-0.15)

ONEOK and ONEOK Partners to Participate in the Tuohy Brothers Annual Energy Conference
PR Newswire - Mon Aug 08, 3:15PM CDT
ONEOK, Inc. (NYSE: OKE) and ONEOK Partners, L.P. (NYSE: OKS) will participate in the Tuohy Brothers Seventh Annual "All-in-One" Energy Conference on Tuesday, Aug. 9, 2016, in New York City.
OKE: 48.62 (-1.02), OKS: 38.65 (-0.61)

Sempra Energy (SRE) Lags Q2 Earnings, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:02AM CDT
Sempra Energy's (SRE) second-quarter 2016 adjusted earnings per share came in at 79 cents, missing the Zacks Consensus Estimate of $1.00 by 21%.
VVC: 51.64 (-0.27), OKE: 48.62 (-1.02), SRE: 109.91 (-0.67), CLNE: 4.30 (-0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...